Correlation of MRI Characteristics with the Histologic Grade of Soft Tissue Sarcoma of the Extremities and Trunk
Abstract
Objective: The staging and treatment of soft tissue sarcoma depend on the histologic grades, which predicts overall survival. This study aimed to assess magnetic resonance imaging (MRI) characteristics to differentiate between low- and high-grade soft tissue sarcomas of the extremities and trunk.
Material and Methods: This retrospective study included patients with soft tissue sarcomas who underwent preoperative MRI between October 2006 and December 2020. The data obtained included qualitative information (size, depth, MRI signal intensity, hemorrhage signal, margin, fascial tail sign, peritumoral edema/enhancement, and organ involvement) and quantitative information (apparent diffusion coefficient value). Logistic regression was performed to identify the MRI characteristics associated with histologic grades.
Results: A total of 101 patients were included; 76 were diagnosed with histologically high-grade tumors. The final multivariate regression model showed a combination of 4 MRI characteristics: a large area of intratumoral heterogeneity on T2-weighted images (T2W), a large area of non-enhancing hyperintensity on T2W, a fascial tail sign, and peritumoral edema. These characteristics collectively predicted high-grade soft tissue sarcoma with 81% accuracy. The 2 strongest indicators were intratumoral heterogeneity on T2W (adjusted odds ratio (aOR) 3.96, 95% confidence interval (95% CI) 1.16-13.55, p-value=0.028) and a fascial tail sign (aOR 3.34, 95%CI 1.09-10.22, p-value=0.035).
Conclusion: The 2 strongest MRI predictors of high-grade soft tissue sarcoma are marked intratumoral heterogeneity on T2W and a fascial tail sign. Furthermore, the combination of 4 MRI characteristics, including marked intratumoral heterogeneity on T2W, a fascial tail sign, non-enhancing hyperintensity on T2W, and peritumoral edema, can increase the accuracy of histologic grade prediction.
Keywords
Full Text:
PDFReferences
Yang J, Ren Z, Du X, Hao M, Zhou W. The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute. Stem Cell Investig 2014;1:18.
Fletcher C, Bridge J, Hogendoorn P, Mertens F. WHO classification of tumours of soft tissue and bone [homepage on the Internet]. Lyon, France: IARC Press; [cited 2024 Dec 21]. Available from: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/WHO-Classification-Of-Tumours-Of-Soft-Tissue-And-Bone-2013
Smolle MA, Andreou D, Tunn PU, Szkandera J, Liegl-Atzwanger B, Leithner A. Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk. EFORT Open Rev 2017;2:421–31.
Coindre JM. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 2006;130:1448–53.
American Cancer Society medical and editorial content team. Survival rates for soft tissue sarcoma [homepage on the Internet]. Atlanta: American Cancer Society; 2021 [cited 2020 Jan 4]. Available from: https://www.cancer.org/cancer/types/soft-tissue-sarcoma/detection-diagnosis-staging/survival-rates.html
von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, et al. Soft Tissue Sarcoma, Version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw JNCCN 2018;16:536–63.
Crombé A, Marcellin PJ, Buy X, Stoeckle E, Brouste V, Italiano A, et al. Soft-Tissue Sarcomas: assessment of MRI features correlating with histologic grade and patient outcome. Radiology 2019;291:710–21.
Zhao F, Ahlawat S, Farahani SJ, Weber KL, Montgomery EA, Carrino JA, et al. Can MR imaging be used to predict tumor grade in soft-tissue sarcoma? Radiology 2014;272:192–201.
Xiang P, Zhang X, Liu D, Wang C, Ding L, Wang F, et al. Distinguishing soft tissue sarcomas of different histologic grades based on quantitative MR assessment of intratumoral heterogeneity. Eur J Radiol 2019;118:194–9.
Scalas G, Parmeggiani A, Martella C, Tuzzato G, Bianchi G, Facchini G, et al. Magnetic resonance imaging of soft tissue sarcoma: features related to prognosis. Eur J Orthop Surg Traumatol Orthop Traumatol 2021;31:1567–75.
Murphey MD, Kransdorf MJ, Smith SE. Imaging of soft tissue neoplasms in the adult: malignant tumors. Semin Musculoskelet Radiol 1999;3:39–58.
Lee SY, Ju MK, Jeon HM, Jeong EK, Lee YJ, Kim CH, et al. Regulation of tumor progression by programmed necrosis. Oxid Med Cell Longev 2018;2018:3537471.
Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F, et al. Comparative study of the National cancer institute and French federation of cancer centers sarcoma group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol Off J Am Soc Clin Oncol 1997;15:350–62.
Galant J, Martí-Bonmatí L, Soler R, Saez F, Lafuente J, Bonmatí C, et al. Grading of subcutaneous soft tissue tumors by means of their relationship with the superficial fascia on MR imaging. Skeletal Radiol 1998;27:657–63.
Yoo HJ, Hong SH, Kang Y, Choi JY, Moon KC, Kim HS, et al. MR imaging of myxofibrosarcoma and undifferentiated sarcoma with emphasis on tail sign; diagnostic and prognostic value. Eur Radiol 2014;24:1749–57.
Engellau J, Bendahl PO, Persson A, Domanski HA, Akerman M, Gustafson P, et al. Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays. Hum Pathol 2005;36:994–1002.
Fernebro J, Wiklund M, Jonsson K, Bendahl PO, Rydholm A, Nilbert M, et al. Focus on the tumour periphery in MRI evaluation of soft tissue sarcoma: infiltrative growth signifies poor prognosis. Sarcoma 2006;2006:21251.
Corino VDA, Montin E, Messina A, Casali PG, Gronchi A, Marchianò A, et al. Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high-grade lesions. J Magn Reson Imaging JMRI 2018;47:829–40.
Schmitz F, Sedaghat S. Inferring malignancy grade of soft tissue sarcomas from magnetic resonance imaging features. A systematic review. Eur J Radiol 2024;177:111548.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.